Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 136 entries
Sorted by: Best Match Show Resources per page
Molecular phylogenetics of slit-faced bats (Chiroptera: Nycteridae) reveal deeply divergent African lineages.

Journal of zoological systematics and evolutionary research = Zeitschrift fur zoologische Systematik und Evolutionsforschung

Demos TC, Webala PW, Kerbis Peterhans JC, Goodman SM, Bartonjo M, Patterson BD.
PMID: 31894177
J Zool Syst Evol Res. 2019 Nov;57(4):1019-1038. doi: 10.1111/jzs.12313. Epub 2019 Aug 20.

The bat family Nycteridae contains only the genus

Cite
Demos TC, Webala PW, Kerbis Peterhans JC, et al. Molecular phylogenetics of slit-faced bats (Chiroptera: Nycteridae) reveal deeply divergent African lineages. J Zool Syst Evol Res. 2019;57(4):1019-1038doi: 10.1111/jzs.12313.
Demos, T. C., Webala, P. W., Kerbis Peterhans, J. C., Goodman, S. M., Bartonjo, M., & Patterson, B. D. (2019). Molecular phylogenetics of slit-faced bats (Chiroptera: Nycteridae) reveal deeply divergent African lineages. Journal of zoological systematics and evolutionary research = Zeitschrift fur zoologische Systematik und Evolutionsforschung, 57(4), 1019-1038. https://doi.org/10.1111/jzs.12313
Demos, Terrence C, et al. "Molecular phylogenetics of slit-faced bats (Chiroptera: Nycteridae) reveal deeply divergent African lineages." Journal of zoological systematics and evolutionary research = Zeitschrift fur zoologische Systematik und Evolutionsforschung vol. 57,4 (2019): 1019-1038. doi: https://doi.org/10.1111/jzs.12313
Demos TC, Webala PW, Kerbis Peterhans JC, Goodman SM, Bartonjo M, Patterson BD. Molecular phylogenetics of slit-faced bats (Chiroptera: Nycteridae) reveal deeply divergent African lineages. J Zool Syst Evol Res. 2019 Nov;57(4):1019-1038. doi: 10.1111/jzs.12313. Epub 2019 Aug 20. PMID: 31894177; PMCID: PMC6919933.
Copy Download .nbib Format: NLM
Synovial and cartilage responsiveness to peri-operative hyaluronic acid ± dexamethasone administration following a limited injury to the rabbit stifle joint.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society

Heard BJ, Barton KI, Abubacker S, Chung M, Martin CR, Schmidt TA, Shrive NG, Hart DA.
PMID: 34061360
J Orthop Res. 2021 Jun 01; doi: 10.1002/jor.25108. Epub 2021 Jun 01.

Posttraumatic osteoarthritis (PTOA) can develop after an injury to the knee. Previous studies have indicated that an intra-articular (IA) injection of the potent glucocorticoid dexamethasone (DEX) may significantly prevent induction of PTOA. The aim of the present study was...

Cite
Heard BJ, Barton KI, Abubacker S, et al. Synovial and cartilage responsiveness to peri-operative hyaluronic acid ± dexamethasone administration following a limited injury to the rabbit stifle joint. J Orthop Res. 2021;doi: 10.1002/jor.25108.
Heard, B. J., Barton, K. I., Abubacker, S., Chung, M., Martin, C. R., Schmidt, T. A., Shrive, N. G., & Hart, D. A. (2021). Synovial and cartilage responsiveness to peri-operative hyaluronic acid ± dexamethasone administration following a limited injury to the rabbit stifle joint. Journal of orthopaedic research : official publication of the Orthopaedic Research Society, . https://doi.org/10.1002/jor.25108
Heard, B J, et al. "Synovial and cartilage responsiveness to peri-operative hyaluronic acid ± dexamethasone administration following a limited injury to the rabbit stifle joint." Journal of orthopaedic research : official publication of the Orthopaedic Research Society vol. (2021). doi: https://doi.org/10.1002/jor.25108
Heard BJ, Barton KI, Abubacker S, Chung M, Martin CR, Schmidt TA, Shrive NG, Hart DA. Synovial and cartilage responsiveness to peri-operative hyaluronic acid ± dexamethasone administration following a limited injury to the rabbit stifle joint. J Orthop Res. 2021 Jun 01; doi: 10.1002/jor.25108. Epub 2021 Jun 01. PMID: 34061360.
Copy Download .nbib Format: NLM
Low MicroRNA-126 Levels in Right Ventricular Endomyocardial Biopsies Coincide With Cardiac Allograft Vasculopathy in Heart Transplant Patients.

Transplantation direct

Heggermont WA, Delrue L, Dierickx K, Dierckx R, Verstreken S, Goethals M, Bartunek J, Vanderheyden M.
PMID: 32548243
Transplant Direct. 2020 Apr 15;6(5):e549. doi: 10.1097/TXD.0000000000000995. eCollection 2020 May.

Endothelium-enriched microRNAs (miRs) are involved in the development of cardiac allograft vasculopathy (CAV). Recently, serum-derived miR-126-3p and -5p, known endothelial microRNAs with a crucial function in angiogenesis and re-endothelialization, provided additional predictive power for cardiac allograft vasculopathy in addition...

Cite
Heggermont WA, Delrue L, Dierickx K, et al. Low MicroRNA-126 Levels in Right Ventricular Endomyocardial Biopsies Coincide With Cardiac Allograft Vasculopathy in Heart Transplant Patients. Transplant Direct. 2020;6(5):e549doi: 10.1097/TXD.0000000000000995.
Heggermont, W. A., Delrue, L., Dierickx, K., Dierckx, R., Verstreken, S., Goethals, M., Bartunek, J., & Vanderheyden, M. (2020). Low MicroRNA-126 Levels in Right Ventricular Endomyocardial Biopsies Coincide With Cardiac Allograft Vasculopathy in Heart Transplant Patients. Transplantation direct, 6(5), e549. https://doi.org/10.1097/TXD.0000000000000995
Heggermont, Ward A, et al. "Low MicroRNA-126 Levels in Right Ventricular Endomyocardial Biopsies Coincide With Cardiac Allograft Vasculopathy in Heart Transplant Patients." Transplantation direct vol. 6,5 (2020): e549. doi: https://doi.org/10.1097/TXD.0000000000000995
Heggermont WA, Delrue L, Dierickx K, Dierckx R, Verstreken S, Goethals M, Bartunek J, Vanderheyden M. Low MicroRNA-126 Levels in Right Ventricular Endomyocardial Biopsies Coincide With Cardiac Allograft Vasculopathy in Heart Transplant Patients. Transplant Direct. 2020 Apr 15;6(5):e549. doi: 10.1097/TXD.0000000000000995. eCollection 2020 May. PMID: 32548243; PMCID: PMC7213604.
Copy Download .nbib Format: NLM
The Effectiveness of Dexmedetomidine as a Prophylactic Treatment for Emergence Delirium Among Combat Veterans With High Anxiety: A Randomized Placebo-Controlled Trial.

Military medicine

Bartoszek M, McGuire JM, Wilson JT, Sorensen JS, Vice TFR, Hudson AJ.
PMID: 34057183
Mil Med. 2021 May 31; doi: 10.1093/milmed/usab212. Epub 2021 May 31.

INTRODUCTION: Emergence delirium (ED) is characterized by agitation, confusion, and violent physical and verbal behavior associated with awakening from general anesthesia. Combat exposure among U.S. military veterans has been identified as a risk factor for ED. Preoperative baseline anxiety...

Cite
Bartoszek M, McGuire JM, Wilson JT, et al. The Effectiveness of Dexmedetomidine as a Prophylactic Treatment for Emergence Delirium Among Combat Veterans With High Anxiety: A Randomized Placebo-Controlled Trial. Mil Med. 2021;doi: 10.1093/milmed/usab212.
Bartoszek, M., McGuire, J. M., Wilson, J. T., Sorensen, J. S., Vice, T. F. R., & Hudson, A. J. (2021). The Effectiveness of Dexmedetomidine as a Prophylactic Treatment for Emergence Delirium Among Combat Veterans With High Anxiety: A Randomized Placebo-Controlled Trial. Military medicine, . https://doi.org/10.1093/milmed/usab212
Bartoszek, Michael, et al. "The Effectiveness of Dexmedetomidine as a Prophylactic Treatment for Emergence Delirium Among Combat Veterans With High Anxiety: A Randomized Placebo-Controlled Trial." Military medicine vol. (2021). doi: https://doi.org/10.1093/milmed/usab212
Bartoszek M, McGuire JM, Wilson JT, Sorensen JS, Vice TFR, Hudson AJ. The Effectiveness of Dexmedetomidine as a Prophylactic Treatment for Emergence Delirium Among Combat Veterans With High Anxiety: A Randomized Placebo-Controlled Trial. Mil Med. 2021 May 31; doi: 10.1093/milmed/usab212. Epub 2021 May 31. PMID: 34057183.
Copy Download .nbib Format: NLM
Titanocenes as anticancer agents: recent insights.

Medicinal chemistry (Shariqah (United Arab Emirates))

Skoupilova H, Hrstka R, Bartosik M.
PMID: 28031018
Med Chem. 2016 Dec 28; Epub 2016 Dec 28.

BACKGROUND: Enormous success of antitumor agent cisplatin initiated interest in other organometallic complexes. A subclass of organometallic compounds termed metallocenes, characterized by a transition metal central atom (M) bound to cyclopentadienide (Cp-/[C5H5]-) ligands with the basic formula Cp2M, has...

Cite
Skoupilova H, Hrstka R, Bartosik M. Titanocenes as anticancer agents: recent insights. Med Chem. 2016;
Skoupilova, H., Hrstka, R., & Bartosik, M. (2016). Titanocenes as anticancer agents: recent insights. Medicinal chemistry (Shariqah (United Arab Emirates)), .
Skoupilova, Hana, et al. "Titanocenes as anticancer agents: recent insights." Medicinal chemistry (Shariqah (United Arab Emirates)) vol. (2016).
Skoupilova H, Hrstka R, Bartosik M. Titanocenes as anticancer agents: recent insights. Med Chem. 2016 Dec 28; Epub 2016 Dec 28. PMID: 28031018.
Copy Download .nbib Format: NLM
Successful ablation of bifocal premature ventricular complexes from both left bundle branches triggering polymorphic ventricular tachycardia in long QT syndrome 2: a case report.

European heart journal. Case reports

Martinek M, Kollias G, Derndorfer M, Pürerfellner H.
PMID: 34988364
Eur Heart J Case Rep. 2021 Dec 21;5(12):ytab518. doi: 10.1093/ehjcr/ytab518. eCollection 2021 Dec.

BACKGROUND: A 19-year-old woman with an established diagnosis of long QT syndrome (LQTS) 2 and underlying KCNH2-mutation was referred to our centre for recurrent polymorphic ventricular tachycardia (VT) and ventricular fibrillation (VF) refractory to medical therapy and bilateral thoracic...

Cite
Martinek M, Kollias G, Derndorfer M, et al. Successful ablation of bifocal premature ventricular complexes from both left bundle branches triggering polymorphic ventricular tachycardia in long QT syndrome 2: a case report. Eur Heart J Case Rep. 2021;5(12):ytab518doi: 10.1093/ehjcr/ytab518.
Martinek, M., Kollias, G., Derndorfer, M., & Pürerfellner, H. (2021). Successful ablation of bifocal premature ventricular complexes from both left bundle branches triggering polymorphic ventricular tachycardia in long QT syndrome 2: a case report. European heart journal. Case reports, 5(12), ytab518. https://doi.org/10.1093/ehjcr/ytab518
Martinek, Martin, et al. "Successful ablation of bifocal premature ventricular complexes from both left bundle branches triggering polymorphic ventricular tachycardia in long QT syndrome 2: a case report." European heart journal. Case reports vol. 5,12 (2021): ytab518. doi: https://doi.org/10.1093/ehjcr/ytab518
Martinek M, Kollias G, Derndorfer M, Pürerfellner H. Successful ablation of bifocal premature ventricular complexes from both left bundle branches triggering polymorphic ventricular tachycardia in long QT syndrome 2: a case report. Eur Heart J Case Rep. 2021 Dec 21;5(12):ytab518. doi: 10.1093/ehjcr/ytab518. eCollection 2021 Dec. PMID: 34988364; PMCID: PMC8715737.
Copy Download .nbib Format: NLM
Locomotion and Topographical Working Memory in Children With Myelomeningocele and Arthrogryposis Multiplex Congenita.

Frontiers in psychiatry

Bartonek Å, Guariglia C, Piccardi L.
PMID: 34867521
Front Psychiatry. 2021 Nov 12;12:729859. doi: 10.3389/fpsyt.2021.729859. eCollection 2021.

No abstract available.

Cite
Bartonek Å, Guariglia C, Piccardi L. Locomotion and Topographical Working Memory in Children With Myelomeningocele and Arthrogryposis Multiplex Congenita. Front Psychiatry. 2021;12:729859doi: 10.3389/fpsyt.2021.729859.
Bartonek, �. �., Guariglia, C., & Piccardi, L. (2021). Locomotion and Topographical Working Memory in Children With Myelomeningocele and Arthrogryposis Multiplex Congenita. Frontiers in psychiatry, 12729859. https://doi.org/10.3389/fpsyt.2021.729859
Bartonek, Åsa, et al. "Locomotion and Topographical Working Memory in Children With Myelomeningocele and Arthrogryposis Multiplex Congenita." Frontiers in psychiatry vol. 12 (2021): 729859. doi: https://doi.org/10.3389/fpsyt.2021.729859
Bartonek Å, Guariglia C, Piccardi L. Locomotion and Topographical Working Memory in Children With Myelomeningocele and Arthrogryposis Multiplex Congenita. Front Psychiatry. 2021 Nov 12;12:729859. doi: 10.3389/fpsyt.2021.729859. eCollection 2021. PMID: 34867521; PMCID: PMC8632943.
Copy Download .nbib Format: NLM
Mass Customized Outlook for Regenerative Heart Failure Care.

International journal of molecular sciences

Yamada S, Bartunek J, Behfar A, Terzic A.
PMID: 34768825
Int J Mol Sci. 2021 Oct 22;22(21). doi: 10.3390/ijms222111394.

Heart failure pathobiology is permissive to reparative intent. Regenerative therapies exemplify an emerging disruptive innovation aimed at achieving structural and functional organ restitution. However, mixed outcomes, complexity in use, and unsustainable cost have curtailed broader adoption, mandating the development...

Cite
Yamada S, Bartunek J, Behfar A, et al. Mass Customized Outlook for Regenerative Heart Failure Care. Int J Mol Sci. 2021;22(21)doi: 10.3390/ijms222111394.
Yamada, S., Bartunek, J., Behfar, A., & Terzic, A. (2021). Mass Customized Outlook for Regenerative Heart Failure Care. International journal of molecular sciences, 22(21), . https://doi.org/10.3390/ijms222111394
Yamada, Satsuki, et al. "Mass Customized Outlook for Regenerative Heart Failure Care." International journal of molecular sciences vol. 22,21 (2021). doi: https://doi.org/10.3390/ijms222111394
Yamada S, Bartunek J, Behfar A, Terzic A. Mass Customized Outlook for Regenerative Heart Failure Care. Int J Mol Sci. 2021 Oct 22;22(21). doi: 10.3390/ijms222111394. PMID: 34768825; PMCID: PMC8583673.
Copy Download .nbib Format: NLM
Terminating the physician-patient relationship.

Texas medicine

Barton HM.
PMID: 7974273
Tex Med. 1994 Sep;90(9):46-9.

No abstract available.

Cite
Barton HM. Terminating the physician-patient relationship. Tex Med. 1994;90(9):46-9
Barton, H. M. (1994). Terminating the physician-patient relationship. Texas medicine, 90(9), 46-9.
Barton, H M. "Terminating the physician-patient relationship." Texas medicine vol. 90,9 (1994): 46-9.
Barton HM. Terminating the physician-patient relationship. Tex Med. 1994 Sep;90(9):46-9. PMID: 7974273.
Copy Download .nbib Format: NLM
Insulin Resistance Predicts Severity of Coronary Atherosclerotic Disease in Non-Diabetic Patients.

Journal of clinical medicine

Strisciuglio T, Izzo R, Barbato E, Di Gioia G, Colaiori I, Fiordelisi A, Morisco C, Bartunek J, Franco D, Ammirati G, Pergola V, Imparato L, Trimarco B, Esposito G, Rapacciuolo A.
PMID: 32646007
J Clin Med. 2020 Jul 07;9(7). doi: 10.3390/jcm9072144.

BACKGROUND: Insulin resistance (IR) in patients with type 2 diabetes mellitus (T2DM) represents a predictor of coronary artery disease (CAD). However, how IR is able to impact the severity of coronary atherosclerosis in non-diabetic patients is unknown.OBJECTIVES: We investigated...

Cite
Strisciuglio T, Izzo R, Barbato E, et al. Insulin Resistance Predicts Severity of Coronary Atherosclerotic Disease in Non-Diabetic Patients. J Clin Med. 2020;9(7)doi: 10.3390/jcm9072144.
Strisciuglio, T., Izzo, R., Barbato, E., Di Gioia, G., Colaiori, I., Fiordelisi, A., Morisco, C., Bartunek, J., Franco, D., Ammirati, G., Pergola, V., Imparato, L., Trimarco, B., Esposito, G., & Rapacciuolo, A. (2020). Insulin Resistance Predicts Severity of Coronary Atherosclerotic Disease in Non-Diabetic Patients. Journal of clinical medicine, 9(7), . https://doi.org/10.3390/jcm9072144
Strisciuglio, Teresa, et al. "Insulin Resistance Predicts Severity of Coronary Atherosclerotic Disease in Non-Diabetic Patients." Journal of clinical medicine vol. 9,7 (2020). doi: https://doi.org/10.3390/jcm9072144
Strisciuglio T, Izzo R, Barbato E, Di Gioia G, Colaiori I, Fiordelisi A, Morisco C, Bartunek J, Franco D, Ammirati G, Pergola V, Imparato L, Trimarco B, Esposito G, Rapacciuolo A. Insulin Resistance Predicts Severity of Coronary Atherosclerotic Disease in Non-Diabetic Patients. J Clin Med. 2020 Jul 07;9(7). doi: 10.3390/jcm9072144. PMID: 32646007; PMCID: PMC7408744.
Copy Download .nbib Format: NLM
Cell-Based Reporter System for High-Throughput Screening of MicroRNA Pathway Inhibitors and Its Limitations.

Frontiers in genetics

Brustikova K, Sedlak D, Kubikova J, Skuta C, Solcova K, Malik R, Bartunek P, Svoboda P.
PMID: 29535760
Front Genet. 2018 Feb 27;9:45. doi: 10.3389/fgene.2018.00045. eCollection 2018.

MicroRNAs (miRNAs) are small RNAs repressing gene expression. They contribute to many physiological processes and pathologies. Consequently, strategies for manipulation of the miRNA pathway are of interest as they could provide tools for experimental or therapeutic interventions. One of...

Cite
Brustikova K, Sedlak D, Kubikova J, et al. Cell-Based Reporter System for High-Throughput Screening of MicroRNA Pathway Inhibitors and Its Limitations. Front Genet. 2018;9:45doi: 10.3389/fgene.2018.00045.
Brustikova, K., Sedlak, D., Kubikova, J., Skuta, C., Solcova, K., Malik, R., Bartunek, P., & Svoboda, P. (2018). Cell-Based Reporter System for High-Throughput Screening of MicroRNA Pathway Inhibitors and Its Limitations. Frontiers in genetics, 945. https://doi.org/10.3389/fgene.2018.00045
Brustikova, Katerina, et al. "Cell-Based Reporter System for High-Throughput Screening of MicroRNA Pathway Inhibitors and Its Limitations." Frontiers in genetics vol. 9 (2018): 45. doi: https://doi.org/10.3389/fgene.2018.00045
Brustikova K, Sedlak D, Kubikova J, Skuta C, Solcova K, Malik R, Bartunek P, Svoboda P. Cell-Based Reporter System for High-Throughput Screening of MicroRNA Pathway Inhibitors and Its Limitations. Front Genet. 2018 Feb 27;9:45. doi: 10.3389/fgene.2018.00045. eCollection 2018. PMID: 29535760; PMCID: PMC5835079.
Copy Download .nbib Format: NLM
Severity of Coronary Atherosclerosis and Risk of Diabetes Mellitus.

Journal of clinical medicine

Colaiori I, Izzo R, Barbato E, Franco D, Di Gioia G, Rapacciuolo A, Bartunek J, Mancusi C, Losi MA, Strisciuglio T, Manzi MV, de Simone G, Trimarco B, Morisco C.
PMID: 31330868
J Clin Med. 2019 Jul 21;8(7). doi: 10.3390/jcm8071069.

BACKGROUND: Cardio-vascular target organ damage predicts the onset of type 2 diabetes mellitus (DM) in hypertensive patients. Whether an increased incidence of DM is also in relation to the severity of coronary atherosclerosis is unknown.OBJECTIVE: We evaluated the onset...

Cite
Colaiori I, Izzo R, Barbato E, et al. Severity of Coronary Atherosclerosis and Risk of Diabetes Mellitus. J Clin Med. 2019;8(7)doi: 10.3390/jcm8071069.
Colaiori, I., Izzo, R., Barbato, E., Franco, D., Di Gioia, G., Rapacciuolo, A., Bartunek, J., Mancusi, C., Losi, M. A., Strisciuglio, T., Manzi, M. V., de Simone, G., Trimarco, B., & Morisco, C. (2019). Severity of Coronary Atherosclerosis and Risk of Diabetes Mellitus. Journal of clinical medicine, 8(7), . https://doi.org/10.3390/jcm8071069
Colaiori, Iginio, et al. "Severity of Coronary Atherosclerosis and Risk of Diabetes Mellitus." Journal of clinical medicine vol. 8,7 (2019). doi: https://doi.org/10.3390/jcm8071069
Colaiori I, Izzo R, Barbato E, Franco D, Di Gioia G, Rapacciuolo A, Bartunek J, Mancusi C, Losi MA, Strisciuglio T, Manzi MV, de Simone G, Trimarco B, Morisco C. Severity of Coronary Atherosclerosis and Risk of Diabetes Mellitus. J Clin Med. 2019 Jul 21;8(7). doi: 10.3390/jcm8071069. PMID: 31330868; PMCID: PMC6678313.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 136 entries